Living with Addison's: Long-Term Health and Well-being
At a Glance
Living long-term with Addison's disease requires lifelong balancing of hormone replacement therapy. Patients need routine monitoring of electrolytes, blood pressure, and bone density, as well as periodic screening for related autoimmune conditions like thyroid disease.
Living with Addison’s disease is a lifelong journey of balance. Once your initial diagnosis is stable, your focus will shift to long-term health monitoring and maintaining a high quality of life. Because you are replacing hormones that your body used to regulate automatically, you and your medical team must now perform that “fine-tuning” manually [1][2].
Routine Long-Term Monitoring
To stay healthy and avoid complications from either too much or too little medication, your doctor should perform regular check-ups [1][3]:
- Blood Pressure and Electrolytes: These help ensure your fludrocortisone dose is keeping your salt and water levels in balance.
- Bone Health: Long-term over-use of glucocorticoids (like hydrocortisone) can increase the risk of osteoporosis (bone thinning) and fractures [4][5]. Periodic DEXA scans (bone density tests) are often recommended to monitor your bone strength [6][4].
- Metabolic Markers: Monitoring your weight, blood sugar, and cholesterol is important, as excessive steroid replacement can lead to weight gain or metabolic changes [1][7].
The Link to Other Conditions
Many people with Addison’s disease have an autoimmune form of the condition. Because the immune system is already prone to attacking healthy tissue, you are at a higher risk of developing other autoimmune disorders. This is often called Autoimmune Polyglandular Syndrome (APS) [8][9].
Your care team should periodically screen you for related conditions, including [8][10]:
- Thyroid Disease: Such as Hashimoto’s or Graves’ disease.
- Type 1 Diabetes: Which requires careful management of both insulin and steroids [11].
- Vitiligo: Loss of skin pigment in patches.
- Celiac Disease: An immune reaction to eating gluten.
The Emotional and Physical Toll
Even with perfect medication levels, many patients find that living with a chronic illness takes an emotional toll.
- Persistent Fatigue: It is common to experience suboptimal cortisol coverage or sudden energy dips, especially during times of minor stress or toward the end of a dose’s cycle [12][13]. If persistent fatigue is drastically impacting your life, some doctors may consider testing or replacing DHEA as an additional supportive therapy [1].
- Mental Health: Studies show that patients with Addison’s may experience higher rates of anxiety, depression, or social isolation [14][15]. Managing a “hidden” illness that requires constant vigilance can be exhausting.
- Quality of Life: Most people with Addison’s lead full lives, but it requires a “new normal.” Using tools like a steroid emergency card and wearing a medical alert ID at all times provides a safety net that can reduce anxiety [16][17].
Building Your Support System
You are the most important member of your care team. Engaging in patient education programs and joining support groups can improve your confidence in managing your health and help you navigate the “invisible” challenges of the disease [18][19]. With proactive monitoring and a strong support network, you can thrive while living with Addison’s [2].
Common questions in this guide
What routine tests do I need when living with Addison's disease?
Why am I still so tired even though I take my Addison's medication?
Am I at risk for other diseases if I have Addison's disease?
How can Addison's medications affect my bone health over time?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How often should we check my thyroid levels and screen for other autoimmune conditions?
- 2.When should I have my first DEXA (bone density) scan to monitor for potential bone thinning?
- 3.My energy levels are still low in the afternoon—should we adjust the timing of my second dose?
- 4.Are my blood pressure and electrolyte levels within the target range on my current fludrocortisone dose?
- 5.Can you recommend a mental health professional who has experience working with patients with chronic endocrine disorders?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (19)
- 1
Autoimmune Addison's disease.
Saverino S, Falorni A
Best practice & research. Clinical endocrinology & metabolism 2020; (34(1)):101379 doi:10.1016/j.beem.2020.101379.
PMID: 32063488 - 2
Addison's disease in pregnancy: Case report, management, and review of the literature.
Margulies SL, Corrigan K, Bathgate S, Macri C
Journal of neonatal-perinatal medicine 2020; (13(2)):275-278 doi:10.3233/NPM-190231.
PMID: 31744021 - 3
Unusual Dosing of Long-Acting Hydrocortisone in a Rapid Hydrocortisone Metabolizer With Addison's Disease: A Case Report.
Sungar NR, Srinivasan B
Cureus 2025; (17(8)):e90553 doi:10.7759/cureus.90553.
PMID: 40978990 - 4
Adrenal crisis after first infusion of zoledronic acid: a case report.
Smrecnik M, Kavcic Trsinar Z, Kocjan T
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2018; (29(7)):1675-1678 doi:10.1007/s00198-018-4508-7.
PMID: 29594318 - 5
Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
Camozzi V, Betterle C, Frigo AC, et al.
Endocrine 2018; (59(2)):319-329 doi:10.1007/s12020-017-1380-8.
PMID: 28795340 - 6
Trabecular bone score and sclerostin concentrations in patients with primary adrenal insufficiency.
Zdrojowy-Wełna A, Halupczok-Żyła J, Słoka N, et al.
Frontiers in endocrinology 2022; (13()):996157 doi:10.3389/fendo.2022.996157.
PMID: 36407318 - 7
Improved Urinary Cortisol Metabolome in Addison Disease: A Prospective Trial of Dual-Release Hydrocortisone.
Espiard S, McQueen J, Sherlock M, et al.
The Journal of clinical endocrinology and metabolism 2021; (106(3)):814-825 doi:10.1210/clinem/dgaa862.
PMID: 33236103 - 8
Adrenal crisis and autoimmune polyglandular syndromes.
Freeland ZK, Lueking R, Tsai-Nguyen G, et al.
Proceedings (Baylor University. Medical Center) 2017; (30(4)):427-428 doi:10.1080/08998280.2017.11930214.
PMID: 28966452 - 9
Adolescent onset of autoimmune polyglandular syndrome type 2.
Murphy SA, Mohd Din FH, O'Grady MJ
BMJ case reports 2022; (15(5)) doi:10.1136/bcr-2022-249839.
PMID: 35606028 - 10
Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1.
Lima Ferreira J, Simões de Carvalho F, Marques AP, Príncipe RM
Endocrinology, diabetes & metabolism case reports 2020; (2020()).
PMID: 33434148 - 11
MANAGEMENT OF ENDOCRINE DISEASE Disease burden and treatment challenges in patients with both Addison's disease and type 1 diabetes mellitus.
Chantzichristos D, Eliasson B, Johannsson G
European journal of endocrinology 2020; (183(1)):R1-R11.
PMID: 32299062 - 12
Decreased physical activity, reduced QoL and presence of debilitating fatigue in patients with Addison's disease.
van der Valk ES, Smans LC, Hofstetter H, et al.
Clinical endocrinology 2016; (85(3)):354-60 doi:10.1111/cen.13059.
PMID: 26953557 - 13
Primary Adrenal Insufficiency (Addison's Disease) Presenting as Sun Tan-Like Skin Pigmentation: A Case Report.
Bondagji MF, Qul H, Nahhas A, et al.
Cureus 2023; (15(12)):e49837 doi:10.7759/cureus.49837.
PMID: 38164302 - 14
A Challenging diagnosis that eventually results in a life-threatening condition: Addison's disease and adrenal crisis.
Joersjö P, Block L
BMJ case reports 2019; (12(12)) doi:10.1136/bcr-2019-231858.
PMID: 31888894 - 15
Acute Mania in a Patient With Primary Adrenal Insufficiency Due to Autoimmune Adrenalitis: A Case Report.
Brown NJ, Wang A, Fote G, et al.
Journal of psychiatric practice 2023; (29(3)):260-263 doi:10.1097/PRA.0000000000000711.
PMID: 37200146 - 16
Guidance for the prevention and emergency management of adult patients with adrenal insufficiency.
Simpson H, Tomlinson J, Wass J, et al.
Clinical medicine (London, England) 2020; (20(4)):371-378 doi:10.7861/clinmed.2019-0324.
PMID: 32675141 - 17
Steroid emergency cards: action needed.
Drug and therapeutics bulletin 2020; (58(11)):163 doi:10.1136/dtb.2020.000063.
PMID: 33082160 - 18
[Adrenal Insufficiency].
Burger-Stritt S, Hahner S
Deutsche medizinische Wochenschrift (1946) 2016; (141(24)):1740-1742 doi:10.1055/s-0042-118276.
PMID: 27903023 - 19
[Addison's disease : Primary adrenal insufficiency].
Pulzer A, Burger-Stritt S, Hahner S
Der Internist 2016; (57(5)):457-69 doi:10.1007/s00108-016-0054-6.
PMID: 27129928
This page is for informational purposes only and does not replace professional medical advice. Always consult your endocrinologist regarding your hormone replacement therapy and long-term care.
Get notified when new evidence is published on Addison disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.